TrialJournal of pain and symptom management2010

Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy.

Thomas J Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.